While it can act as a suppressor under specific experimental conditions, deregulated TPI1—particularly in extracellular vehicles (EVs)—has been shown to promote aerobic glycolysis and enhance tumor aggressiveness [44, 45]. Here, TPI1 is linked to neoplasm.